GeneSearch™ Breast Lymph Node (BLN) Assay Post Approval Study
Sponsor: Janssen Diagnostics, LLC
Terminated
GeneSearch™ BLN Assay has been voluntarily withdrawn from the US market.
Other terminated trials from Janssen Diagnostics, LLC
More terminations from Janssen Diagnostics, LLC
This observational or N/A phase trial investigates Breast Cancer and is currently terminated or withdrawn. Janssen Diagnostics, LLC leads this study, which shows 12 recorded versions since 2007 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Terminated
-
Sep 2024 — Sep 2025 [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Dec 2021 — Jul 2024 [monthly]
Terminated
-
Jan 2021 — Dec 2021 [monthly]
Terminated
▶ Show 7 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Terminated
-
Jun 2018 — Nov 2020 [monthly]
Terminated
-
May 2018 — Jun 2018 [monthly]
Terminated
-
Apr 2018 — May 2018 [monthly]
Terminated
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Terminated NA
-
Feb 2017 — Aug 2017 [monthly]
Terminated NA
-
Jan 2017 — Feb 2017 [monthly]
Terminated NA
First recorded
Dec 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Janssen Diagnostics, LLC
For direct contact, visit the study record on ClinicalTrials.gov .